The use of haloperidol in the agitated, critically ill pediatric patient with burns
Title
The use of haloperidol in the agitated, critically ill pediatric patient with burns
Creator
Brown RL; Henke A; Greenhalgh DG; Warden GD
Identifier
Publisher
The Journal Of Burn Care & Rehabilitation
Date
1996
Subject
Child; Female; Humans; Male; Critical Illness; Treatment Outcome; Medical Records; adolescent; Preschool; infant; retrospective studies; Antipsychotic Agents/administration & dosage/adverse effects/therapeutic use; Burns/complications/drug therapy; Haloperidol/administration & dosage/adverse effects/therapeutic use; Psychomotor Agitation/drug therapy/etiology/physiopathology
Description
Haloperidol has become the drug of choice for sedation of the acutely agitated, delirious adult patient in the critical care setting because of its well-documented efficacy and lack of major side effects. Its use in the critically ill pediatric patient with burns has not been described. To determine the safety and efficacy of haloperidol in this population, the medical records of 30 critically ill pediatric patients with burns treated with haloperidol during the period 1986 to 1992 were reviewed. Our findings support the safe and effective use of haloperidol to treat severe agitation and delirium in the critically ill pediatric patient. The intravenous route appears to be more effective than the enteral route and should be considered when rapid, acute control of agitation is required.
1996
Rights
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
Journal Article
Citation List Month
Backlog
URL Address
Citation
Brown RL; Henke A; Greenhalgh DG; Warden GD, “The use of haloperidol in the agitated, critically ill pediatric patient with burns,” Pediatric Palliative Care Library, accessed April 26, 2024, https://pedpalascnetlibrary.omeka.net/items/show/11993.